Joanna Hewett, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 3546 State Route 27, Kendall Park, NJ 08824 Phone: 609-483-3411 |
Mrs. Shira Sheldon, APN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 3270 State Route 27, Suite 1200, Kendall Park, NJ 08824 Phone: 732-422-2400 Fax: 732-463-6087 |
Mr. Jason D Smith, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3674 Route 27, Princeton Radiology Associates, P.a., Department B, Kendall Park, NJ 08824 Phone: 732-821-5563 Fax: 732-821-6675 |
Sasha Dacosta-chambers, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 11 Wharton Ct, Kendall Park, NJ 08824 Phone: 646-533-5633 |
Rima A Patel, AGPCNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3546 Route 27, Kendall Park, NJ 08824 Phone: 609-483-3411 Fax: 609-483-3421 |
Jin Hee Ang, Nurse Practitioner - Adult Health Medicare: Medicare Enrolled Practice Location: 6 Sturgis Rd, Kendall Park, NJ 08824 Phone: 609-468-8701 |
Padama Misra, AGNP-C Nurse Practitioner - Gerontology Medicare: Not Enrolled in Medicare Practice Location: 1 Oakey Dr, Kendall Park, NJ 08824 Phone: 917-617-5488 |
Arica Somaiah, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 22 Barbara St, Kendall Park, NJ 08824 Phone: 646-262-3677 |
News Archive
As opioid overdose deaths rose during the COVID-19 pandemic, people seeking treatment for opioid addiction had to wait nearly twice as long to begin methadone treatment in the United States than in Canada, a new Yale study has shown.
In an attempt to overcome these issues, a team of researchers from various departments at the University of California San Diego recently proposed using biomimetic virus-like particles (VLPs) as positive controls for assays used in SARS-CoV-2 detection. Their study is published on the preprint server bioRxiv.
Updated public standards incorporating new tests for impurities as well as more modern technologies to help ensure the quality of over-the-counter (OTC) ingredients and products will be key areas of focus for a September 8-9, 2011, workshop co-sponsored by the U.S. Food & Drug Administration (FDA) and the U.S. Pharmacopeial Convention.
Imaging Diagnostic Systems, Inc., a pioneer in laser breast imaging, announced today that a Premarket Notification 510(k) was submitted on Monday, November 22, 2010, to the United States Food and Drug Administration (FDA). With this submission, the company moves forward in the process of seeking marketing clearance for its innovative breast imaging device, the CTLM system.
› Verified 6 days ago